Supreme Court hears Trump tariff case on Wednesday
Digest more
The chances of businesses getting tariff refunds grew significantly on Wednesday after the Trump administration’s case to keep most of his levies in place was met with deep skepticism from multiple conservative and liberal justices.
We don’t expect any demand from China to return to the U.S. market with this change,’ said one trader at an international trading company. ‘Brazil is cheaper than the United States and even non-Chinese buyers are taking Brazilian cargoes.
In arguments before the Supreme Court, the White House backed away from its claims that President Trump’s tariffs were about raising revenue.
21hon MSN
The conservative justices nerded out on legal theory, and other takeaways from the tariff arguments
While Trump seeks to advance his trade agenda, some conservative justices appeared eager to advance an agenda of their own. Members of the court’s GOP-appointed majority sharply questioned the administration’s tariffs using a pair of legal doctrines important to conservatives’ long-running battle to rein in the so-called administrative state.
3hon MSN
Clarus targets $7.8M in tariff mitigation for 2026 while advancing apparel and Adventure growth
Q3 2025 Management View Executive Chairman Warren Kanders reported that Clarus generated net sales of $69.3 million, a 3% year-over-year increase, with quarterly adjusted EBITDA up 15%. Kanders highlighted,
By Noel John and Pablo Sinha (Reuters) -Gold prices edged up on Thursday, buoyed by a weaker dollar and a resurgence of safe-haven demand on concerns over a prolonged U.S. government shutdown and uncertainty over the legality of tariffs.
13hon MSN
SCOTUS tariff decision may be too late for the holidays, says Bank of America's Lorraine Hutchinson
Lorraine Hutchinson, Bank of America Securities senior retail analyst, joins 'The Exchange' to discuss the holiday retail season, how the analyst's workflow changes around the SCOTUS decision and much more.
Novo Nordisk (NVO) and Eli Lilly (LLY) announced a major drug-pricing deal with the Trump administration on Thursday, receiving relief from tariffs in exchange for lower prices for their branded medicines,